161Tb-labeled radiopharmaceuticals targeting mucin receptors for treatment of pancreatic cancer

Institut KU LEUVEN
Phd a commencé le

Mentor

Ooms Maarten

Co-mentor

Segers Charlotte

Promoteur

Cleeren Frederik

Candidat(e)

Van Laere Camille